Hyperlactatemia and human immunodeficiency virus infection: Lessons from the era of antiretroviral monotherapy [1]

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3683-

  Chariot, Patrick ^a   Bourokba, Nacer ^a   Monnet, Isabelle ^a   Gherardi, Romain ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; LACTIC ACID; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

BLOOD SAMPLING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS INFECTION;

ACIDOSIS, LACTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS;

EID: 0036838250     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3683.2002     Document Type: Letter

References (8)

1. Bissuel, F., F. Bruneel, F. Habersetzer, D. Chassard, L. Cotte, M. Chevallier, J. Bernuau, J. C. Lucet, and C. Trepo. 1994. Fulminant hepatitis with severe lactic acidosis in HIV-infected patients on didanosine therapy. J. Intern. Med. 235:367-372.
2. Carr, A., and D. A. Cooper. 2000. Adverse effects of antiretroviral therapy. Lancet 356:1423-1430.
3. Chariot, P., I. Drogou, I. de Lacroix-Szmania, M. C. Eliezer-Vanerot, B. Chazaud, A. Lombès, A. Schaeffer, and E. S. Zafrani. 1999. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J. Hepatol. 29:156-160.
4. Chariot, P., R. Ratiney, M. Ammi-Said, R. Herigault, S. Adnot, and R. Gherardi. 1994. Optimal handling of blood samples for lactate and pyruvate routine determination. Arch. Pathol. Lab. Med. 118:695-697.
5. Côté, H. C. F., Z. L. Brumme, K. J. P. Craib, C. S. Alexander, B. Wynhoven, L. Ting, H. Wong, M. Harris, P. R. Harrigan, M. V. O'Shaughnessy, and J. S. G. Montaner. 2002. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N. Engl. J. Med. 346:811-820.
6. John, M., C. B. Moore, I. R. James, D. Nolan, R. P. Upton, E. J. McKinnon, and S. A. Mallal. 2001. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 15:717-723.
7. Lenzo, N. P., B. A. Garas, and M. A. French. 1997. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS 11:1294-1296.
8. Lonergan, J. T., C. Behling, H. Pfander, T. I. Hassanein, and W. C. Mathews. 2000. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin. Infect. Dis. 31:162-166.